The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Colorectal Cancer Therapeutics Market Research Report 2025
Synopsis
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time
The global Colorectal Cancer Therapeutics market was valued at US$ 12130 million in 2023 and is anticipated to reach US$ 17070 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Therapeutics.
Report Scope
The Colorectal Cancer Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Hospitals
Clinic
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time
The global Colorectal Cancer Therapeutics market was valued at US$ 12130 million in 2023 and is anticipated to reach US$ 17070 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Therapeutics.
Report Scope
The Colorectal Cancer Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Hospitals
Clinic
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Therapeutics Market Perspective (2019-2030)
2.2 Colorectal Cancer Therapeutics Growth Trends by Region
2.2.1 Global Colorectal Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Colorectal Cancer Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Colorectal Cancer Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Colorectal Cancer Therapeutics Market Dynamics
2.3.1 Colorectal Cancer Therapeutics Industry Trends
2.3.2 Colorectal Cancer Therapeutics Market Drivers
2.3.3 Colorectal Cancer Therapeutics Market Challenges
2.3.4 Colorectal Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Therapeutics Players by Revenue
3.1.1 Global Top Colorectal Cancer Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Colorectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Therapeutics Revenue
3.4 Global Colorectal Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Therapeutics Revenue in 2023
3.5 Colorectal Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2025-2030)
5 Colorectal Cancer Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Colorectal Cancer Therapeutics Market Size (2019-2030)
6.2 North America Colorectal Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Colorectal Cancer Therapeutics Market Size by Country (2019-2024)
6.4 North America Colorectal Cancer Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Therapeutics Market Size (2019-2030)
7.2 Europe Colorectal Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Colorectal Cancer Therapeutics Market Size by Country (2019-2024)
7.4 Europe Colorectal Cancer Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Colorectal Cancer Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Therapeutics Market Size (2019-2030)
9.2 Latin America Colorectal Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Colorectal Cancer Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Colorectal Cancer Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Colorectal Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Taiho Pharma
11.1.1 Taiho Pharma Company Detail
11.1.2 Taiho Pharma Business Overview
11.1.3 Taiho Pharma Colorectal Cancer Therapeutics Introduction
11.1.4 Taiho Pharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.1.5 Taiho Pharma Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Colorectal Cancer Therapeutics Introduction
11.2.4 Merck KGaA Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.2.5 Merck KGaA Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Colorectal Cancer Therapeutics Introduction
11.3.4 Amgen Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Colorectal Cancer Therapeutics Introduction
11.4.4 Takeda Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.4.5 Takeda Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Colorectal Cancer Therapeutics Introduction
11.5.4 Roche Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Colorectal Cancer Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Colorectal Cancer Therapeutics Introduction
11.7.4 Sanofi Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Regeneron
11.8.1 Regeneron Company Detail
11.8.2 Regeneron Business Overview
11.8.3 Regeneron Colorectal Cancer Therapeutics Introduction
11.8.4 Regeneron Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.8.5 Regeneron Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Colorectal Cancer Therapeutics Introduction
11.9.4 Bayer Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Onyx
11.10.1 Onyx Company Detail
11.10.2 Onyx Business Overview
11.10.3 Onyx Colorectal Cancer Therapeutics Introduction
11.10.4 Onyx Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.10.5 Onyx Recent Development
11.11 Bristol-Myers Squib
11.11.1 Bristol-Myers Squib Company Detail
11.11.2 Bristol-Myers Squib Business Overview
11.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Introduction
11.11.4 Bristol-Myers Squib Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.11.5 Bristol-Myers Squib Recent Development
11.12 Sumitomo Dainippon Pharma
11.12.1 Sumitomo Dainippon Pharma Company Detail
11.12.2 Sumitomo Dainippon Pharma Business Overview
11.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Introduction
11.12.4 Sumitomo Dainippon Pharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.12.5 Sumitomo Dainippon Pharma Recent Development
11.13 Array BioPharma
11.13.1 Array BioPharma Company Detail
11.13.2 Array BioPharma Business Overview
11.13.3 Array BioPharma Colorectal Cancer Therapeutics Introduction
11.13.4 Array BioPharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.13.5 Array BioPharma Recent Development
11.14 Hutchison MediPharma
11.14.1 Hutchison MediPharma Company Detail
11.14.2 Hutchison MediPharma Business Overview
11.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Introduction
11.14.4 Hutchison MediPharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.14.5 Hutchison MediPharma Recent Development
11.15 Jiangsu Hengrui Medicine
11.15.1 Jiangsu Hengrui Medicine Company Detail
11.15.2 Jiangsu Hengrui Medicine Business Overview
11.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Introduction
11.15.4 Jiangsu Hengrui Medicine Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.15.5 Jiangsu Hengrui Medicine Recent Development
11.16 Jiangsu Chia-Tai Tianqing
11.16.1 Jiangsu Chia-Tai Tianqing Company Detail
11.16.2 Jiangsu Chia-Tai Tianqing Business Overview
11.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Introduction
11.16.4 Jiangsu Chia-Tai Tianqing Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.16.5 Jiangsu Chia-Tai Tianqing Recent Development
11.17 Suzhou Zelgen Biopharmaceuticals
11.17.1 Suzhou Zelgen Biopharmaceuticals Company Detail
11.17.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Introduction
11.17.4 Suzhou Zelgen Biopharmaceuticals Revenue in Colorectal Cancer Therapeutics Business (2019-2024)
11.17.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Colorectal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Colorectal Cancer Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Colorectal Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Colorectal Cancer Therapeutics Market Share by Region (2019-2024)
Table 8. Global Colorectal Cancer Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Colorectal Cancer Therapeutics Market Share by Region (2025-2030)
Table 10. Colorectal Cancer Therapeutics Market Trends
Table 11. Colorectal Cancer Therapeutics Market Drivers
Table 12. Colorectal Cancer Therapeutics Market Challenges
Table 13. Colorectal Cancer Therapeutics Market Restraints
Table 14. Global Colorectal Cancer Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Colorectal Cancer Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Colorectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Therapeutics as of 2023)
Table 17. Ranking of Global Top Colorectal Cancer Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Colorectal Cancer Therapeutics Product Solution and Service
Table 21. Date of Enter into Colorectal Cancer Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Colorectal Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Colorectal Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Colorectal Cancer Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Colorectal Cancer Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Colorectal Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Colorectal Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Colorectal Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Colorectal Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Colorectal Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Colorectal Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Colorectal Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Taiho Pharma Company Detail
Table 47. Taiho Pharma Business Overview
Table 48. Taiho Pharma Colorectal Cancer Therapeutics Product
Table 49. Taiho Pharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 50. Taiho Pharma Recent Development
Table 51. Merck KGaA Company Detail
Table 52. Merck KGaA Business Overview
Table 53. Merck KGaA Colorectal Cancer Therapeutics Product
Table 54. Merck KGaA Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Merck KGaA Recent Development
Table 56. Amgen Company Detail
Table 57. Amgen Business Overview
Table 58. Amgen Colorectal Cancer Therapeutics Product
Table 59. Amgen Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Amgen Recent Development
Table 61. Takeda Company Detail
Table 62. Takeda Business Overview
Table 63. Takeda Colorectal Cancer Therapeutics Product
Table 64. Takeda Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Roche Company Detail
Table 67. Roche Business Overview
Table 68. Roche Colorectal Cancer Therapeutics Product
Table 69. Roche Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Eli Lilly Company Detail
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Colorectal Cancer Therapeutics Product
Table 74. Eli Lilly Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. Sanofi Company Detail
Table 77. Sanofi Business Overview
Table 78. Sanofi Colorectal Cancer Therapeutics Product
Table 79. Sanofi Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Regeneron Company Detail
Table 82. Regeneron Business Overview
Table 83. Regeneron Colorectal Cancer Therapeutics Product
Table 84. Regeneron Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 85. Regeneron Recent Development
Table 86. Bayer Company Detail
Table 87. Bayer Business Overview
Table 88. Bayer Colorectal Cancer Therapeutics Product
Table 89. Bayer Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Onyx Company Detail
Table 92. Onyx Business Overview
Table 93. Onyx Colorectal Cancer Therapeutics Product
Table 94. Onyx Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 95. Onyx Recent Development
Table 96. Bristol-Myers Squib Company Detail
Table 97. Bristol-Myers Squib Business Overview
Table 98. Bristol-Myers Squib Colorectal Cancer Therapeutics Product
Table 99. Bristol-Myers Squib Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 100. Bristol-Myers Squib Recent Development
Table 101. Sumitomo Dainippon Pharma Company Detail
Table 102. Sumitomo Dainippon Pharma Business Overview
Table 103. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product
Table 104. Sumitomo Dainippon Pharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 105. Sumitomo Dainippon Pharma Recent Development
Table 106. Array BioPharma Company Detail
Table 107. Array BioPharma Business Overview
Table 108. Array BioPharma Colorectal Cancer Therapeutics Product
Table 109. Array BioPharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 110. Array BioPharma Recent Development
Table 111. Hutchison MediPharma Company Detail
Table 112. Hutchison MediPharma Business Overview
Table 113. Hutchison MediPharma Colorectal Cancer Therapeutics Product
Table 114. Hutchison MediPharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 115. Hutchison MediPharma Recent Development
Table 116. Jiangsu Hengrui Medicine Company Detail
Table 117. Jiangsu Hengrui Medicine Business Overview
Table 118. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product
Table 119. Jiangsu Hengrui Medicine Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 120. Jiangsu Hengrui Medicine Recent Development
Table 121. Jiangsu Chia-Tai Tianqing Company Detail
Table 122. Jiangsu Chia-Tai Tianqing Business Overview
Table 123. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product
Table 124. Jiangsu Chia-Tai Tianqing Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 125. Jiangsu Chia-Tai Tianqing Recent Development
Table 126. Suzhou Zelgen Biopharmaceuticals Company Detail
Table 127. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 128. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product
Table 129. Suzhou Zelgen Biopharmaceuticals Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 130. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Colorectal Cancer Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Diagnostics Features
Figure 4. Therapeutics Features
Figure 5. Global Colorectal Cancer Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Colorectal Cancer Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Research Institutions Case Studies
Figure 10. Colorectal Cancer Therapeutics Report Years Considered
Figure 11. Global Colorectal Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Colorectal Cancer Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Colorectal Cancer Therapeutics Market Share by Region: 2023 VS 2030
Figure 14. Global Colorectal Cancer Therapeutics Market Share by Players in 2023
Figure 15. Global Top Colorectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Therapeutics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Therapeutics Revenue in 2023
Figure 17. North America Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Colorectal Cancer Therapeutics Market Share by Country (2019-2030)
Figure 19. United States Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Colorectal Cancer Therapeutics Market Share by Country (2019-2030)
Figure 23. Germany Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Colorectal Cancer Therapeutics Market Share by Region (2019-2030)
Figure 31. China Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Colorectal Cancer Therapeutics Market Share by Country (2019-2030)
Figure 39. Mexico Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Colorectal Cancer Therapeutics Market Share by Country (2019-2030)
Figure 43. Turkey Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Taiho Pharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 46. Merck KGaA Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 47. Amgen Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 48. Takeda Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 50. Eli Lilly Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 51. Sanofi Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 52. Regeneron Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 53. Bayer Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 54. Onyx Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 55. Bristol-Myers Squib Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 56. Sumitomo Dainippon Pharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 57. Array BioPharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 58. Hutchison MediPharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 59. Jiangsu Hengrui Medicine Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 60. Jiangsu Chia-Tai Tianqing Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 61. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
